Passive Heat Therapy for People With COPD — COPD  

Cardiovascular Diseases Clinical Trial

Official title: The Acute and Chronic Benefits of Passive Heat Therapy for People With COPD

Status Recruiting

Clinical Trial Summary

People with Chronic Obstructive Pulmonary Disease (COPD) often develop high blood pressure and heart disease due to their sedentary lifestyle and difficulty exercising. The investigators will test if heating can mimic the health benefits of exercise by monitoring the increase in leg blood-flow using ultrasound during a 45-minute hot-water footbath. The patients will then undergo 6-weeks of hot-water footbaths to examine whether the changes to blood-flow lead to improvements in blood pressure and other indicators of heart disease risk.

Clinical Trial Description

People with COPD are at higher risk of developing cardiovascular disease (CVD). While exercise training is a potent therapy for CVD, people with COPD have a low tolerance for exercise due to dyspnea and premature muscle fatigue. Thus, there is a need to develop more effective strategies to improve CVD risk in people with COPD. A novel way to reduce blood pressure and enhance arterial health is with passive heat therapy (PHT). An acute 45-min bout of lower limb hot-water immersion has been shown to increase leg blood flow and reduce blood pressure in healthy older adults, suggesting that PHT could have similar hypotensive and anti-atherosclerotic effects as exercise. Augmenting leg blood flow with PHT may also have functional benefits by reducing peripheral muscle fatigue and improving exercise tolerance. No study to date has looked at the acute and chronic hemodynamic and vascular responses to PHT in people with COPD, nor whether it can acutely or chronically improve exercise tolerance. ;

Related Conditions & MeSH terms

• Cardiovascular Diseases
• COPD

• NCT number: NCT05962164
• Study type: Interventional
• Source: University of British Columbia
• Contact: Neil Eves, PhD
• Phone: (250) 807-9676
• Email: neil.eves@ubc.ca
• Status: Recruiting
• Phase: N/A
• Start date: August 17, 2023
• Completion date: December 31, 2024